AstraZeneca-CEO snuffelt aan Galapagos–partner Gilead | De …
AstraZeneca-CEO snuffelt aan Galapagos–partner Gilead Schermvullende weergave CEO Pascal Soriot en de Britse farmareus AstraZeneca hebben het Amerikaanse Gilead Sciences …
Executive Team – Galapagos NV
Executive Team. Onno van de Stolpe – Chief Executive Officer. Onno van de Stolpe founded our company in 1999 and has served as our Chief Executive Officer and a member of our board of directors from 1999 to the present. From 1998 to 1999, he was the Managing Director of Genomics at IntroGene BV (later Crucell NV, which was acquired by Johnson …
PRESS RELEASE: Galapagos Announces Expanded Relationship …
Galapagos Announces Expanded Relationship with AstraZeneca MECHELEN, BELGIUM — Aug 8, 2007 — Mechelen, Belgium; 8 August 2007 – Galapagos NV announced today that its service
Galapagos names new CFO | FierceBiotech
Belgium’s Galapagos announced the appointment of Guillaume Jetten as chief financial officer. Jetten succeeds Leo Steenbergen, who will continue to serve as Galapagos’ CFO until July and will assist
Board of Directors – Galapagos NV
Daniel O’Day has served as a member of our board of directors since October 22, 2019. Mr. O’Day joined Gilead in 2019 to lead the biopharmaceutical company, which has more than 11,000 employees around the world. Prior to Gilead, Mr. O’Day served as the chief executive officer of Roche Pharmaceuticals.
Galapagos : Publication of the annual report and …
Nomination of Mr. Peter Guenter for Galapagos’ board of directors Mechelen, Belgium; 29 March 2019, 22.15 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) published its annual report for the financial year 2018.
Galapagos verhoogt kapitaal door uitoefening van warrant …
Als gevolg van de uitoefening van de Initiële Warrant A, heeft Gilead ingeschreven op 2.617.791 aandelen tegen €140,59 per aandeel, voor een totaalbedrag van €368.035.236,69. De nieuwe …
Galapagos Shares Surge on $5.1 Billion Gilead Investment …
Jul 15, 2019Andre Hoekema, chief business officer at Galapagos, discusses the $5.1 billion investment into the company by Gilead Sciences Inc. He speaks with Bloomberg’s Nejra Cehic on “Bloomberg Surveillance.”
GALAPAGOS NV : Stock Market News and Information | GLPG …
Mechelen, Belgium; 17 April 2020, 22.01 CET; regulated information — Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its board of directors created 2,280,500 subscription rights 1 under new subscription right plans for the benefit of the personnel of the company and its subsidiaries.. On 17 April 2020, the board of directors of Galapagos approved “Subscription Right Plan …
GalapagosH – Luxembourg Stock Exchange
The New Prospectus Regime On 21 July 2019, the new EU Prospectus Regulation, along with the new Luxembourg Prospectus Act, fully entered into force. MiFID II/MiFIR LuxSE has adjusted its internal framework to ensure that it complies with the new MiFID II/MiFIR framework, entering into force on January 2018.
